| Title |
Patent cliff and strategic switch: exploring strategic design possibilities in the pharmaceutical industry
|
|---|---|
| Published in |
SpringerPlus, May 2016
|
| DOI | 10.1186/s40064-016-2323-1 |
| Pubmed ID | |
| Authors |
Chie Hoon Song, Jeung-Whan Han |
| Abstract |
Extending the period of the market exclusivity and responding properly to the recent agglomeration of patent expiries are pivotal to the success of pharmaceutical companies. Declining R&D productivity, rising costs of commercialization, near-term patent expirations for many top-selling drugs are forcing companies to adopt new systems to introduce innovative products to market and to focus on strategies that increase the returns from the existing product portfolio. This systematic review explores various strategic and tactical management approaches by synthesizing the relevant literature and practical examples on patent expiration strategies. It further discusses how the mix of competition policies and strategic instruments can be used to maintain declining revenue streams from the blockbuster business model of the pharmaceutical industry. The review provides a comprehensive overview of the research on various strategies, offers both theoretical and practical guidelines for strategy transformation that companies can use to prolong the market exclusivity, and identifies knowledge gaps that needed to be addressed in order to improve efficiency in policy design. |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Canada | 1 | 33% |
| Unknown | 2 | 67% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 3 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 236 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 1 | <1% |
| Unknown | 235 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 53 | 22% |
| Student > Bachelor | 35 | 15% |
| Student > Ph. D. Student | 27 | 11% |
| Researcher | 14 | 6% |
| Other | 9 | 4% |
| Other | 21 | 9% |
| Unknown | 77 | 33% |
| Readers by discipline | Count | As % |
|---|---|---|
| Business, Management and Accounting | 26 | 11% |
| Pharmacology, Toxicology and Pharmaceutical Science | 22 | 9% |
| Biochemistry, Genetics and Molecular Biology | 21 | 9% |
| Engineering | 13 | 6% |
| Chemistry | 13 | 6% |
| Other | 61 | 26% |
| Unknown | 80 | 34% |
Attention Score in Context
This research output has an Altmetric Attention Score of 15. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 August 2021.
All research outputs
#2,016,040
of 22,957,478 outputs
Outputs from SpringerPlus
#121
of 1,853 outputs
Outputs of similar age
#37,452
of 333,862 outputs
Outputs of similar age from SpringerPlus
#12
of 195 outputs
Altmetric has tracked 22,957,478 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,853 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.7. This one has done particularly well, scoring higher than 93% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 333,862 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 195 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 93% of its contemporaries.